SCHEMBL844345

SCHEMBL844345

O=Cc1c[nH]c2c1ccc1c2[nH]c2cc(Cl)cc(Cl)c21

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PIM3 Q86V86 10/20 0.59
PIM1 P11309 8/20 0.59
PIM2 Q9P1W9 2/20 0.59
TRIM24 O15164 1/20 0.42
TRIM33 Q9UPN9 1/20 0.42
CYP2A6 P11509 2/20 0.40
IMPDH2 P12268 1/20 0.40
KDM4E B2RXH2 1/20 0.37
ALDH1A1 P00352 1/20 0.37
MAPT P10636 1/20 0.37
CCNE2 O96020 1/20 0.36
CDK4 P11802 1/20 0.36
CCND1 P24385 1/20 0.36
CCNE1 P24864 1/20 0.36
CDK2 P24941 1/20 0.36
CAMK2B Q13554 1/20 0.36
CAMK2G Q13555 1/20 0.36
CAMK2D Q13557 1/20 0.36
CAMK2A Q9UQM7 1/20 0.36
TDP1 Q9NUW8 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL844604 0.74 PIM3 (1.00) PIM3PIM1PIM2TRIM24TRIM33
SCHEMBL844764 0.74 PIM3 (1.00) PIM3PIM1PIM2TRIM24TRIM33
SCHEMBL29394851 0.74 PIM3 (1.00) PIM3PIM1PIM2TRIM24TRIM33
SCHEMBL7074768 0.73 GPR17 (0.46) CYP2A6IMPDH2KDM4EALDH1A1MAPT
SCHEMBL671157 0.73 ERN1 (0.44) PIM3PIM1PIM2TRIM24TRIM33
SCHEMBL844615 0.71 CDK4 (0.49) PIM3ALDH1A1CCNE2CDK4CCND1
SCHEMBL844626 0.70 PIM3 (1.00) PIM3PIM1PIM2TRIM24TRIM33
SCHEMBL844512 0.70 PIM3 (1.00) PIM3PIM1PIM2TRIM24TRIM33
SCHEMBL844836 0.70 PIM3 (0.70) PIM3PIM1PIM2TRIM24TRIM33
SCHEMBL845204 0.70 PIM3 (0.70) PIM3PIM1PIM2TRIM24TRIM33

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8481586-B2 Pyrrolo[2,3-a] carbazoles and use thereof as PIM kinase inhibitors CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (FR) 2013-07-09 US claimed
EP-2326649-B1 NOVEL PYRROLO[2,3-a]CARBAZOLES AND USE THEREOF AS PIM KINASE INHIBITORS CENTRE NAT RECH SCIENT (FR) 2012-03-28 EP claimed
US-20110263669-A1 Novel Pyrrolo [2,3-A] Carbazoles and Use Thereof as PIM Kinase Inhibitors UNIVERSITE BLAISE PASCAL-CLERMONT-FERRAND II (FR) 2011-10-27 US claimed
JP-2011526610-A 2011-10-13 JP claimed
EP-2326649-A1 NOVEL PYRROLO Ý2,3-A¨CARBAZOLES AND USE THEREOF AS PIM KINASE INHIBITORS Centre National de la Recherche Scientifique (FR) 2011-06-01 EP claimed
WO-2010000978-A1 NOVEL PYRROLO [2,3-A] CARBAZOLES AND USE THEREOF AS PIM KINASE INHIBITORS CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (FR) 2010-01-07 WO claimed
US-8481586-B2 Pyrrolo[2,3-a] carbazoles and use thereof as PIM kinase inhibitors CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (FR) 2013-07-09 US disclosed
US-8481586-B2 Pyrrolo[2,3-a] carbazoles and use thereof as PIM kinase inhibitors CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (FR) 2013-07-09 US disclosed
US-8481586-B2 Pyrrolo[2,3-a] carbazoles and use thereof as PIM kinase inhibitors CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (FR) 2013-07-09 US disclosed
EP-2326649-B1 NOVEL PYRROLO[2,3-a]CARBAZOLES AND USE THEREOF AS PIM KINASE INHIBITORS CENTRE NAT RECH SCIENT (FR) 2012-03-28 EP disclosed
EP-2326649-B1 NOVEL PYRROLO[2,3-a]CARBAZOLES AND USE THEREOF AS PIM KINASE INHIBITORS CENTRE NAT RECH SCIENT (FR) 2012-03-28 EP disclosed
US-20110263669-A1 Novel Pyrrolo [2,3-A] Carbazoles and Use Thereof as PIM Kinase Inhibitors UNIVERSITE BLAISE PASCAL-CLERMONT-FERRAND II (FR) 2011-10-27 US disclosed
US-20110263669-A1 Novel Pyrrolo [2,3-A] Carbazoles and Use Thereof as PIM Kinase Inhibitors UNIVERSITE BLAISE PASCAL-CLERMONT-FERRAND II (FR) 2011-10-27 US disclosed
US-20110263669-A1 Novel Pyrrolo [2,3-A] Carbazoles and Use Thereof as PIM Kinase Inhibitors UNIVERSITE BLAISE PASCAL-CLERMONT-FERRAND II (FR) 2011-10-27 US disclosed
EP-2326649-A1 NOVEL PYRROLO Ý2,3-A¨CARBAZOLES AND USE THEREOF AS PIM KINASE INHIBITORS Centre National de la Recherche Scientifique (FR) 2011-06-01 EP disclosed
WO-2010000978-A1 NOVEL PYRROLO [2,3-A] CARBAZOLES AND USE THEREOF AS PIM KINASE INHIBITORS CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (FR) 2010-01-07 WO disclosed
WO-2010000978-A1 NOVEL PYRROLO [2,3-A] CARBAZOLES AND USE THEREOF AS PIM KINASE INHIBITORS CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (FR) 2010-01-07 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110263669-A1 Novel Pyrrolo [2,3-A] Carbazoles and Use Thereof as PIM Kinase Inhibitors PIM3, PIM1, PIM2 PIM3 1/4885PIM1 2/4885PIM2 3/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.